Article info

Download PDFPDF

Response to: ‘Correspondence on ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’ by Micheroli et al’ by Huang et al
Free

Authors

  1. Correspondence to Professor Adrian Ciurea, Department of Rheumatology, University Hospital Zurich, Zurich CH-8091, Switzerland; adrian.ciurea{at}usz.ch
View Full Text

Citation

Ciurea A, Micheroli R
Response to: ‘Correspondence on ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’ by Micheroli et al’ by Huang et al

Publication history

  • Received August 17, 2020
  • Accepted August 18, 2020
  • First published September 15, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.